Followers | 179 |
Posts | 4101 |
Boards Moderated | 0 |
Alias Born | 12/22/2014 |
Tuesday, March 03, 2015 12:48:06 PM
MCIG Market Cap: 36.2 million most likely more due to OS #'s not being up to date. Total liabilities(Debt):$6,943
https://www.otcmarkets.com/stock/MCIG/profile -------------------------Net Earnings
Quarter 4 Revenue (Dec 2013) - $ 85K........ Revenue Cost:$ 31k = $54k
Quarter 1 Revenue (Mar 2014) - $259k........ Revenue Cost:$127k = $132k
Quarter 2 Revenue (Jun 2014) - $196k........ Revenue Cost:$ 97k = $99k
Quarter 3 Revenue (Sep 2014) - $160k........ Revenue Cost:$ 69k = $91k
Next quarter expect 150k lol
http://www.otcmarkets.com/stock/MCIG/financials
Assets:$2,162,672
VAPE Market Cap: 6.8 million most likely more due to OS #'s not being up to date. Total liabilities(Debt):$719,490
http://www.otcmarkets.com/stock/VAPE/profile ---------------------Net Earnings
Quarter 4 Revenue (Dec 2013) - NA ........ Revenue Cost: NA = NA
Quarter 1 Revenue (Mar 2014) - $362k........ Revenue Cost:$356k = $6k
Quarter 2 Revenue (Jun 2014) - $449k........ Revenue Cost:$ 93k = $356k
Quarter 3 Revenue (Sep 2014) - $387k........ Revenue Cost:$150k = $187k
Next quarter expect 400k lol
http://www.otcmarkets.com/stock/VAPE/financials#
Assets:$1,183,976
VAPR Market Cap: 3.9 million most likely more due to OS #'s not being up to date. Total liabilities(Debt):$328,823
http://www.otcmarkets.com/stock/VAPR/profile ----------------------Net Earnings
Quarter 4 Revenue (Dec 2013) - NA.......... Revenue Cost: NA = NA
Quarter 1 Revenue (Mar 2014) - NA.......... Revenue Cost: NA = NA
Quarter 2 Revenue (Jun 2014) - NA.......... Revenue Cost:$ 8k = NA
Quarter 3 Revenue (Sep 2014) - NA.......... Revenue Cost: NA = NA
Next quarter expect NA lol
http://www.otcmarkets.com/stock/VAPR/financials
Assets:$26,117
VPOR**** Market Cap: 4.75 million... (CEO will pay more debt with cash soon)
Total liabilities(Debt):$1,600,000
-------------------------------------------------------------------------------Net Earnings
Quarter 4 Revenue (Dec 2013) - $792K........ Revenue Cost:$405k = $387k
Quarter 1 Revenue (Mar 2014) - $966k........ Revenue Cost:$321k = $645k
Quarter 2 Revenue (Jun 2014) - $1,025,000... Revenue Cost:$517 = $508K
Quarter 3 Revenue (Sep 2014) - $1,308,000... Revenue Cost:$430 = $878K
Next quarter expect 1.5-2 million dollars...(Release before March 31st)
Assets:$3,555,710
Recent HCMC News
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/23/2024 09:05:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 02:06:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:54:19 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/03/2023 09:30:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/11/2023 11:28:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/11/2023 11:25:41 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/11/2023 11:21:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/08/2023 08:00:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/28/2023 08:00:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/24/2023 09:11:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/21/2023 08:30:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2023 09:30:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2023 08:30:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:30:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:30:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/28/2023 08:25:38 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM